Asct chemotherapy and autologous stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy22

Stem Cells Hematopoietic Stem Cells Autografts Embryonic Stem Cells Adult Stem Cells Mesenchymal Stromal Cells Bone Marrow Pluripotent Stem Cells T-Lymphocytes Neural Stem Cells Bone Marrow Cells Cells, Cultured Induced Pluripotent Stem Cells Multipotent Stem Cells Antilymphocyte Serum Fetal Stem Cells Fetal Blood Neoplastic Stem Cells Spermatogonia Plant Stems Allografts Blood Cells

Organisms4

Transplantation Chimera Mice, Inbred C57BL Cytomegalovirus Mice, SCID

Diseases54

Multiple Myeloma Hodgkin Disease Lymphoma, Non-Hodgkin Recurrence Graft vs Host Disease Hematologic Neoplasms Lymphoma, Mantle-Cell Amyloidosis Lymphoma, Follicular Lymphoma, T-Cell, Peripheral Lymphoma Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Leukemia, Myeloid, Acute Lymphoma, B-Cell Myelodysplastic Syndromes Enteropathy-Associated T-Cell Lymphoma Neoplasms, Second Primary Leukemia, Plasma Cell Neoplasm Recurrence, Local Leukemia, Myeloid Neutropenia Leukemia Acute Disease Neoplasms Disease Progression Breast Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Lymphoma, AIDS-Related Hepatic Veno-Occlusive Disease Hematologic Diseases Neuroblastoma Stomatitis Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Mucositis Anemia, Aplastic Infection Medulloblastoma Severe Combined Immunodeficiency Thrombocytopenia Chromosome Aberrations Lymphoproliferative Disorders Central Nervous System Neoplasms Opportunistic Infections Leukemia, Lymphocytic, Chronic, B-Cell Postoperative Complications Disease Models, Animal Paraproteinemias Blood Group Incompatibility Bone Neoplasms Mycoses Lung Neoplasms Sarcoma, Ewing

Chemicals and Drugs50

Melphalan Etoposide Cyclophosphamide Myeloablative Agonists Cytarabine Carmustine Thiotepa Vincristine Doxorubicin Boronic Acids Busulfan Dexamethasone Pyrazines Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents, Alkylating Antigens, CD34 Thalidomide Ifosfamide Antineoplastic Agents Prednisone Granulocyte Colony-Stimulating Factor Podophyllotoxin Mitoxantrone Idarubicin Cisplatin Carboplatin Immunosuppressive Agents Antibodies, Monoclonal Keratins, Type II Immunoglobulin Light Chains Amino Acid Transport System ASC Vidarabine Bleomycin HLA Antigens Methotrexate Antilymphocyte Serum Immunoconjugates Stem Cell Factor Recombinant Proteins Cyclosporine Prednisolone Minor Histocompatibility Antigens Antigens, CD20 Antigens, CD Immunologic Factors Nitrogen Mustard Compounds Biological Markers Tacrolimus Myeloma Proteins Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment94

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Antineoplastic Combined Chemotherapy Protocols Transplantation Conditioning Transplantation, Homologous Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Disease-Free Survival Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Bone Marrow Purging Survival Analysis Whole-Body Irradiation Retrospective Studies Prognosis Follow-Up Studies Liver Transplantation Induction Chemotherapy Mesenchymal Stem Cell Transplantation Leukapheresis Maintenance Chemotherapy Cord Blood Stem Cell Transplantation Cell Transplantation Kidney Transplantation Infusions, Spinal Prospective Studies Blood Component Removal Chemotherapy, Adjuvant Histocompatibility Testing Feasibility Studies Drug Administration Schedule Fatal Outcome Radioimmunotherapy Life Tables Risk Factors Neoplasm Staging Heart Transplantation Immunotherapy Lung Transplantation Kaplan-Meier Estimate Clinical Trials as Topic Blood Transfusion, Autologous Organ Transplantation Transplantation, Isogeneic Lymphocyte Transfusion Flow Cytometry Treatment Failure Pilot Projects Transplantation Immunosuppression Islets of Langerhans Transplantation Positron-Emission Tomography Lymphocyte Depletion Predictive Value of Tests Randomized Controlled Trials as Topic Cell Separation Immunophenotyping Platelet Count Pancreas Transplantation Multivariate Analysis Transplantation, Heterologous Proportional Hazards Models Cell Culture Techniques Donor Selection Severity of Illness Index Immunomagnetic Separation Radiotherapy Leukocyte Count Stem Cell Research Drug Therapy Cohort Studies Cell- and Tissue-Based Therapy Fetal Tissue Transplantation Disease Models, Animal Infusions, Intravenous Colony-Forming Units Assay Transplantation, Heterotopic Incidence Immunohistochemistry Actuarial Analysis Blood Cell Count Immunotherapy, Adoptive Neoadjuvant Therapy Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Lymphocyte Count Platelet Transfusion Heart-Lung Transplantation Cell Count

Psychiatry and Psychology1

Phenomena and Processes27

Graft Survival Time Factors Cell Differentiation Histocompatibility Hematopoiesis Graft vs Leukemia Effect Transplantation Immunology Dose-Response Relationship, Drug Stem Cell Niche Graft Rejection Graft vs Tumor Effect Chimerism Cell Lineage Cell Proliferation Platelet Count Regeneration Drug Resistance, Neoplasm Immunocompromised Host Transplantation Tolerance Chromosome Aberrations Leukocyte Count Virus Activation Cell Survival Blood Cell Count Lymphocyte Count Cell Count Phenotype

Disciplines and Occupations2

Stem Cell Research Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Siblings Quality of Life

Humanities1

Quality of Life

Information Science4

Survival Rate Fatal Outcome Life Tables Incidence

Named Groups4

Tissue Donors Siblings Unrelated Donors Living Donors

Health Care26

Treatment Outcome Disease-Free Survival Survival Rate Survival Analysis Retrospective Studies Follow-Up Studies Prospective Studies Feasibility Studies Fatal Outcome Life Tables Risk Factors Kaplan-Meier Estimate Clinical Trials as Topic Treatment Failure Pilot Projects Predictive Value of Tests Randomized Controlled Trials as Topic Age Factors Multivariate Analysis Proportional Hazards Models Donor Selection Severity of Illness Index Cohort Studies Incidence Actuarial Analysis Tissue and Organ Procurement

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Stem Cell Transplantation Peripheral Blood Stem Cell Transplantation Multiple Myeloma Melphalan Antineoplastic Combined Chemotherapy Protocols Transplantation Conditioning Transplantation, Homologous Combined Modality Therapy Treatment Outcome Remission Induction Salvage Therapy Stem Cells Disease-Free Survival Etoposide Hodgkin Disease Cyclophosphamide Myeloablative Agonists Lymphoma, Non-Hodgkin Cytarabine Recurrence Carmustine Survival Rate Hematopoietic Stem Cell Mobilization Bone Marrow Transplantation Graft vs Host Disease Thiotepa Vincristine Bone Marrow Purging Survival Analysis Hematologic Neoplasms Lymphoma, Mantle-Cell Whole-Body Irradiation Amyloidosis Retrospective Studies Doxorubicin Boronic Acids Hematopoietic Stem Cells Busulfan Dexamethasone Prognosis Pyrazines Graft Survival Antibodies, Monoclonal, Murine-Derived Lymphoma, Follicular Follow-Up Studies Antineoplastic Agents, Alkylating Lymphoma, T-Cell, Peripheral Antigens, CD34 Autografts Thalidomide Ifosfamide Liver Transplantation Antineoplastic Agents Induction Chemotherapy Time Factors Mesenchymal Stem Cell Transplantation Prednisone Leukapheresis Granulocyte Colony-Stimulating Factor Lymphoma Podophyllotoxin Maintenance Chemotherapy Lymphoma, Large B-Cell, Diffuse Neoplasm, Residual Transplantation Chimera Tissue Donors Leukemia, Myeloid, Acute Cord Blood Stem Cell Transplantation Cell Transplantation Lymphoma, B-Cell Mitoxantrone Kidney Transplantation Myelodysplastic Syndromes Enteropathy-Associated T-Cell Lymphoma Embryonic Stem Cells Neoplasms, Second Primary Idarubicin Leukemia, Plasma Cell Infusions, Spinal Cisplatin Carboplatin Prospective Studies Adult Stem Cells Blood Component Removal Chemotherapy, Adjuvant Immunosuppressive Agents Neoplasm Recurrence, Local Histocompatibility Testing Antibodies, Monoclonal Feasibility Studies Drug Administration Schedule Leukemia, Myeloid Fatal Outcome Cell Differentiation Keratins, Type II Neutropenia Radioimmunotherapy Life Tables

No FAQ available that match "asct chemotherapy and autologous stem cell transplantation"